Insider · CIK 0001985604
Linda Burkly
officer
Files at EDIT (Editas Medicine, Inc.). First filing Mar 5, 2025, latest Sep 4, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 6
$0 bought, $24k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EDIT: Editas Medicine, Inc.
EDITOct 9, 2026 · close 2.90
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | Editas Medicine, Inc. | $2,153 709 shares | -1% | - | |
| 10Weak | Editas Medicine, Inc. | $1,535 713 shares | -1% | +141% from low-43% from high | |
| 10Weak | Editas Medicine, Inc. | $1,843 710 shares | -1% | +155% from low-37% from high | |
| 3Weak | Editas Medicine, Inc. | $13k 5,121 shares | -7% | +156% from low-36% from high | |
| 10Weak | Editas Medicine, Inc. | $1,252 726 shares | -1% | +86% from low-54% from high | |
| 10Weak | Editas Medicine, Inc. | $4,946 2,891 shares | -4% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | EDIT Editas Medicine, Inc. | SOpen-market sale Common Stock10b5-1 | -709 | $3.04 | $2,153 | 61,660 | 38 d ago |
| Dec 3, 2025 | EDIT Editas Medicine, Inc. | SOpen-market sale Common Stock10b5-1 | -713 | $2.15 | $1,535 | 68,777 | Dec 4, 2025 |
| Sep 3, 2025 | EDIT Editas Medicine, Inc. | SOpen-market sale Common Stock10b5-1 | -710 | $2.60 | $1,843 | 69,490 | Sep 4, 2025 |
| Jul 31, 2025 | EDIT Editas Medicine, Inc. | SOpen-market sale Common Stock10b5-1 | -5,121 | $2.49 | $13k | 64,398 | Aug 4, 2025 |
| Jun 3, 2025 | EDIT Editas Medicine, Inc. | SOpen-market sale Common Stock10b5-1 | -726 | $1.72 | $1,252 | 69,519 | Jun 4, 2025 |
| Mar 8, 2025 | EDIT Editas Medicine, Inc. | AGrant or award Stock Option (right to buy)derivative | +275,100 | $0.00 | $0 | 275,100 | Mar 27, 2025 |
| Mar 8, 2025 | EDIT Editas Medicine, Inc. | AGrant or award Stock Option (right to buy)derivative | +70,000 | $0.00 | $0 | 70,000 | Mar 27, 2025 |
| Mar 4, 2025 | EDIT Editas Medicine, Inc. | SOpen-market sale Common Stock10b5-1 | -2,891 | $1.71 | $4,946 | 70,245 | Mar 5, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.